RSV stands for Respiratory Syncytial Virus. It is a highly contagious virus that primarily affects the respiratory tract of infants and young children. RSV can also cause severe respiratory illness in older adults, individuals with weakened immune systems, and those with underlying medical conditions.
RSV is a member of the Paramyxoviridae family and is classified as a pneumovirus. The virus is transmitted through respiratory droplets when an infected person coughs or sneezes. It can also be spread through direct contact with surfaces or objects contaminated with the virus. RSV infections commonly occur during fall, winter, and early spring.
The symptoms of RSV infection resemble those of a common cold and may include runny nose, cough, wheezing, sneezing, fever, and sore throat. In severe cases, especially among infants and older adults, RSV infection can lead to bronchiolitis, an inflammation of the small airways in the lungs, or pneumonia.
Prevention and treatment measures for RSV include good hand hygiene, proper respiratory etiquette, avoiding close contact with infected individuals, and ensuring a clean environment. There is no specific antiviral treatment for RSV, but supportive care such as maintaining hydration and relieving symptoms can help manage the illness.
Due to the potentially serious complications associated with RSV, vaccines and prophylactic antibody treatments are available for certain high-risk populations, like premature infants or infants with certain heart or lung conditions. It is essential to promptly seek medical attention if symptoms worsen or breathing difficulties arise, particularly in infants and individuals at higher risk for severe illness.
